Abstract
The great diversity of structural conformations available to proteins allows this class of molecules to carry out the vast majority of biochemical functions in the cell. In order to function adequately, proteins must be synthesized, folded/assembled and degraded with great temporal and spatial accuracy. Precise coordination of multiple processes, including ribosome assembly and movement along mRNA, charging and recycling of tRNAs, recruitment and action of molecular chaperones, and tight control of the degradation machinery is essential to create and maintain a stable proteome. It has become recently evident that even slight errors in any of these processes may lead to disease states. Accordingly, increasing numbers of human diseases have been identified that are due to mutations in genes encoding proteins involved in this so-called “protein quality control”. Since these processes are essential for the production and maintenance of the entire proteome of the cell, the deleterious effects of these mutations often extend far beyond the faulty gene. This review provides an overview of human disorders caused by defects in mechanisms underlying protein biogenesis and stability.
Keywords: Chaperone, degradation, mutation, protein folding, protein synthesis, translation, mRNA, tRNAs, protein quality control, rRNA, enzymes, antibodies, cytoskeletal proteins, channels, motor proteins, cell signaling, nucleic acid polymerases, cellular homeostasis, CFTR, protein degradation, Aminoacylation, ATP-dependent reaction, polypeptide, double sieve, GTP, elongation, lease factors, codons, codon adaptation index, cytosol, ribosome, phosphoryl, UPS, lysosomal degradation, ubiquitin, genome, cytoplasm, GARS, CMT, CMT2D, neurons, DBA, RPS19, SNPs, SRR, JBS, AIRE, FANCL, Protein biogenesisChaperone, degradation, mutation, protein folding, protein synthesis, translation, mRNA, tRNAs, protein quality control, rRNA, enzymes, antibodies, cytoskeletal proteins, channels, motor proteins, cell signaling, nucleic acid polymerases, cellular homeostasis, CFTR, protein degradation, Aminoacylation, ATP-dependent reaction, polypeptide, double sieve, GTP, elongation, lease factors, codons, codon adaptation index, cytosol, ribosome, phosphoryl, UPS, lysosomal degradation, ubiquitin, genome, cytoplasm, GARS, CMT, CMT2D, neurons, DBA, RPS19, SNPs, SRR, JBS, AIRE, FANCL, Protein biogenesis
Protein & Peptide Letters
Title: Disorders of Protein Biogenesis and Stability
Volume: 18 Issue: 2
Author(s): John F. Anderson, Efrain Siller and Jose M. Barral
Affiliation:
Keywords: Chaperone, degradation, mutation, protein folding, protein synthesis, translation, mRNA, tRNAs, protein quality control, rRNA, enzymes, antibodies, cytoskeletal proteins, channels, motor proteins, cell signaling, nucleic acid polymerases, cellular homeostasis, CFTR, protein degradation, Aminoacylation, ATP-dependent reaction, polypeptide, double sieve, GTP, elongation, lease factors, codons, codon adaptation index, cytosol, ribosome, phosphoryl, UPS, lysosomal degradation, ubiquitin, genome, cytoplasm, GARS, CMT, CMT2D, neurons, DBA, RPS19, SNPs, SRR, JBS, AIRE, FANCL, Protein biogenesisChaperone, degradation, mutation, protein folding, protein synthesis, translation, mRNA, tRNAs, protein quality control, rRNA, enzymes, antibodies, cytoskeletal proteins, channels, motor proteins, cell signaling, nucleic acid polymerases, cellular homeostasis, CFTR, protein degradation, Aminoacylation, ATP-dependent reaction, polypeptide, double sieve, GTP, elongation, lease factors, codons, codon adaptation index, cytosol, ribosome, phosphoryl, UPS, lysosomal degradation, ubiquitin, genome, cytoplasm, GARS, CMT, CMT2D, neurons, DBA, RPS19, SNPs, SRR, JBS, AIRE, FANCL, Protein biogenesis
Abstract: The great diversity of structural conformations available to proteins allows this class of molecules to carry out the vast majority of biochemical functions in the cell. In order to function adequately, proteins must be synthesized, folded/assembled and degraded with great temporal and spatial accuracy. Precise coordination of multiple processes, including ribosome assembly and movement along mRNA, charging and recycling of tRNAs, recruitment and action of molecular chaperones, and tight control of the degradation machinery is essential to create and maintain a stable proteome. It has become recently evident that even slight errors in any of these processes may lead to disease states. Accordingly, increasing numbers of human diseases have been identified that are due to mutations in genes encoding proteins involved in this so-called “protein quality control”. Since these processes are essential for the production and maintenance of the entire proteome of the cell, the deleterious effects of these mutations often extend far beyond the faulty gene. This review provides an overview of human disorders caused by defects in mechanisms underlying protein biogenesis and stability.
Export Options
About this article
Cite this article as:
F. Anderson John, Siller Efrain and M. Barral Jose, Disorders of Protein Biogenesis and Stability, Protein & Peptide Letters 2011; 18 (2) . https://dx.doi.org/10.2174/092986611794475075
DOI https://dx.doi.org/10.2174/092986611794475075 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Roles of Medicinal Plants and Constituents in Gynecological Cancer Therapy: Current Literature and Future Directions
Current Topics in Medicinal Chemistry Emerging Immunotargets in Bladder Cancer
Current Drug Targets Current Targets for Anticancer Drug Discovery
Current Drug Targets Structure Based Drug Design for HIV Protease: From Molecular Modeling to Cheminformatics
Current Topics in Medicinal Chemistry Radioiodinated Agents for Imaging Multidrug Resistant Tumors
Medicinal Chemistry Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Current Medicinal Chemistry The Role of Celecoxib as a Potential Inhibitor in the Treatment of Inflammatory Diseases - A Review
Current Medicinal Chemistry Antioxidant Properties of Melatonin and its Potential Action in Diseases
Current Topics in Medicinal Chemistry Bleomycin Induced Sensitivity to TRAIL/Apo-2L-Mediated Apoptosis in Human Seminomatous Testicular Cancer Cells is Correlated with Upregulation of Death Receptors
Anti-Cancer Agents in Medicinal Chemistry Cytokines and Chemokines as Regulators of Angiogenesis in Health and Disease
Current Pharmaceutical Design Current Treatment Concepts of Philadelphia-Negative MPN
Current Cancer Drug Targets Approaches Targeting KV10.1 Open a Novel Window for Cancer Diagnosis and Therapy
Current Medicinal Chemistry Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase
Current Drug Targets The Prolyl-Aminodipeptidases and their Inhibitors as Therapeutic Targets for Fibrogenic Disorders
Mini-Reviews in Medicinal Chemistry Thrombocytopenia in HIV Disease: Clinical Relevance, Physiopathology and Management
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Current Advances in the Development of Anticancer Drugs Targeting Tyrosine Kinases of the Src Family
Current Drug Therapy Stem Cell Guardians – Old and New Perspectives in LSC Biology
Current Drug Targets Kinase Inhibitors Targeting Anti-angiogenesis as Anti-cancer Therapies
Current Angiogenesis (Discontinued) VEGF Signaling in Cancer Treatment
Current Pharmaceutical Design Electric cable: cytoskeleton as an electric transmitter for cancer therapy
Current Signal Transduction Therapy